Screener / SEC EDGAR /CIK 0001551306 /10-K filed Feb 27, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
Nasdaq Health care · Health Services

Progyny, Inc. PGNY

Progyny is a global leader in women’s health and family building solutions. 10-K, Item 1

Headquarters
New York, NY
CEO
Peter Anevski
Next results
around Jan 11, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $1.3B through the costs to a net profit of $58.5M · income statement of the 10-K

7% operating margin
Revenue to Gross profit: $304.5MRevenue to Cost of revenue: $984.2MGross profit to Operating profit: $85.3MGross profit to Operating expenses: $219.2MOperating profit to Net profit: $58.5MOperating profit to Tax & other: $26.8MOperating expenses to R&D: $9.5MOperating expenses to Sales, admin & other: $209.7M Revenue: $1.3B REVENUE $1.3B +10% Y/Y Gross profit: $304.5M · 24% margin GROSS PROFIT $304.5M 24% margin · +20% Y/Y Cost of revenue: $984.2M · 76% of revenue COST OF REVENUE $984.2M 76% of revenue Operating profit: $85.3M · 7% margin OPERATING PROFIT $85.3M 7% margin · +26% Y/Y Operating expenses: $219.2M · 17% of revenue OPERATING EXPENSES $219.2M 17% of revenue Net profit: $58.5M · 5% margin NET PROFIT $58.5M 5% margin · +8% Y/Y Tax & other: $26.8M · 2% of revenue TAX & OTHER $26.8M 2% of revenue R&D: $9.5M · 1% of revenue R&D $9.5M 1% of revenue Sales, admin & other: $209.7M · 16% of revenue SALES, ADMIN & OTHER $209.7M 16% of revenue
Gross profit $304.5M 24% margin · +20% Y/Y
Operating profit $85.3M 7% margin · +26% Y/Y
Net profit $58.5M 5% margin · +8% Y/Y
The full income statement, year by year

PGNY among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.

Compare
Revenue growth: 10.4%, above 49% of 154 peers (their median 10.5%) REVENUE GROWTH 10.4% · above 49% Gross margin: 24.9%, above 8% of 107 peers (their median 63.8%) GROSS MARGIN 24.9% · above 8% Operating margin: 9.4%, above 49% of 138 peers (their median 10.2%) OPERATING MARGIN 9.4% · above 49% Net margin: 6.8%, above 50% of 153 peers (their median 6.7%) NET MARGIN 6.8% · above 50% FCF margin: 13.4%, above 60% of 144 peers (their median 9.9%) FCF MARGIN 13.4% · above 60% Return on capital: 12.6%, above 73% of 89 peers (their median 9.0%) RETURN ON CAPITAL 12.6% · above 73%
PGNY Peer median Below the median

What changed

4 new risk paragraphs. 10-K filed Feb 27, 2026 against Mar 3, 2025.

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

10 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 10 checks found nothing to note

  • Receivables -6.4% ($235.3M to $220.3M) vs revenue +10.4% ($1.2B to $1.3B), -16.8 pts apart
  • Cash from operations $210.2M vs net income $58.5M (FY ending Dec 31, 2025)
  • Same auditor in both 10-Ks: Ernst & Young LLP
7 more checks with nothing to note
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Table of Contents; Accrued Receivables and Accrued Claims Payable
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

4 paragraphs in Risk Factors that were not in the 10-K filed Mar 3, 2025. Quoted as filed.

All 4 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Mar 3, 2025 10-K, ITEM 1A
    The global economy has also been impacted by geopolitical tensions. There is currently significant uncertainty about future trade relationships between the United States and various other countries. Further escalation of specific trade tensions, or more broadly in global trade conflicts, could materially and adversely affect the…
  2. Item 1A · new paragraph · not in the 10-K filed Mar 3, 2025 10-K, ITEM 1A
    Our use of artificial intelligence may subject us to new or heightened legal, regulatory, ethical, operational or other challenges. We use, and may in the future continue to use, artificial intelligence (“AI”), including generative AI, in connection with our business and operations, including for internal operational and productivity…

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$786.9M$1.1B$1.2B$1.3B
Net income$30.4M$62.0M$54.3M$58.5M
Operating cash flow$80.4M$188.8M$179.1M$210.2M
Free cash flow$77.2M$185.2M$173.7M$191.8M

Revenue, FY2017 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$1.3B ▲ 10.4% in FY2025

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

11 filings in the last 30 days · SEC EDGAR

All filings
6 more

About the company

Progyny, Inc., New York, NY · from the 10-K filed Feb 27, 2026

Progyny is a global leader in women’s health and family building solutions. We envision a world where everyone can realize their dreams of family and ideal health. Our mission is to empower healthier, supported journeys through transformative fertility, family building and women’s health benefits. Through our differentiated approach to benefits plan design, member education and support and active network management, our clients’ employees are able to pursue the most effective treatment across life’s milestones from the best providers and specialists and achieve optimal outcomes.

Headquarters
New York, NY
Country
United States
Reports in
USD
Listed on
Nasdaq
Fiscal year ends
December 31
Last results
Nov 4, 2026
Incorporated in
DE

Email alerts

Sources

The 10-K filed Feb 27, 2026 (open at SEC), compared with the 10-K filed Mar 3, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PGNY/export.csv") into a cell.

Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.